SE0201662D0 - Pharmaceutical combination - Google Patents
Pharmaceutical combinationInfo
- Publication number
- SE0201662D0 SE0201662D0 SE0201662A SE0201662A SE0201662D0 SE 0201662 D0 SE0201662 D0 SE 0201662D0 SE 0201662 A SE0201662 A SE 0201662A SE 0201662 A SE0201662 A SE 0201662A SE 0201662 D0 SE0201662 D0 SE 0201662D0
- Authority
- SE
- Sweden
- Prior art keywords
- compound
- pharmaceutical combination
- pharmaceutically
- derivateive
- complicaiton
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (19)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0201662A SE0201662D0 (sv) | 2002-05-31 | 2002-05-31 | Pharmaceutical combination |
TW092113322A TW200307686A (en) | 2002-05-31 | 2003-05-16 | Pharmaceutical combination |
JP2004509650A JP2005532345A (ja) | 2002-05-31 | 2003-05-27 | 薬学的組み合わせ |
PCT/SE2003/000854 WO2003101956A1 (en) | 2002-05-31 | 2003-05-27 | Pharmaceutical combination |
AU2003232711A AU2003232711A1 (en) | 2002-05-31 | 2003-05-27 | Pharmaceutical combination |
CNA038117347A CN1656066A (zh) | 2002-05-31 | 2003-05-27 | 联合药物 |
CA002486110A CA2486110A1 (en) | 2002-05-31 | 2003-05-27 | Pharmaceutical combination |
RU2004131868/15A RU2004131868A (ru) | 2002-05-31 | 2003-05-27 | Фармацевтическая комбинация |
MXPA04011910A MXPA04011910A (es) | 2002-05-31 | 2003-05-27 | Combinacion farmaceutica. |
BR0311138-5A BR0311138A (pt) | 2002-05-31 | 2003-05-27 | Produto combinado, método de preparação do mesmo, kit de partes, método de tratamento de arritmia, e, usos de um produto combinado e de um composto |
PL03373409A PL373409A1 (en) | 2002-05-31 | 2003-05-27 | Pharmaceutical combination |
EP03756136A EP1513807A1 (en) | 2002-05-31 | 2003-05-27 | Pharmaceutical combination |
US10/516,426 US20060052314A1 (en) | 2002-05-31 | 2003-05-27 | Pharmaceutical combination |
ARP030101881A AR040138A1 (es) | 2002-05-31 | 2003-05-28 | Combinacion de compuestos, conjunto de partes (kit), metodo para preparar un conjunto de partes (kit) y uso de dicha combinacion de compuestos en la fabricacion de un medicamento |
NO20044673A NO20044673L (no) | 2002-05-31 | 2004-10-28 | Farmasoytisk kombinasjon |
ZA200408787A ZA200408787B (en) | 2002-05-31 | 2004-10-29 | Pharmaceutical combination. |
IL16516904A IL165169A0 (en) | 2002-05-31 | 2004-11-11 | A combination of thrombin inhibitor of a particular class or a pharmaceutically-acceptable derivative thereof and certain antiarrhythmic oxabispidinesor pharmaceutically-acceptable salts thereof |
CO04120030A CO5631429A2 (es) | 2002-05-31 | 2004-11-29 | Combinacion farmaceutica |
IS7581A IS7581A (is) | 2002-05-31 | 2004-12-03 | Lyfjasamsetning |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0201662A SE0201662D0 (sv) | 2002-05-31 | 2002-05-31 | Pharmaceutical combination |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0201662D0 true SE0201662D0 (sv) | 2002-05-31 |
Family
ID=20288040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0201662A SE0201662D0 (sv) | 2002-05-31 | 2002-05-31 | Pharmaceutical combination |
Country Status (19)
Country | Link |
---|---|
US (1) | US20060052314A1 (sv) |
EP (1) | EP1513807A1 (sv) |
JP (1) | JP2005532345A (sv) |
CN (1) | CN1656066A (sv) |
AR (1) | AR040138A1 (sv) |
AU (1) | AU2003232711A1 (sv) |
BR (1) | BR0311138A (sv) |
CA (1) | CA2486110A1 (sv) |
CO (1) | CO5631429A2 (sv) |
IL (1) | IL165169A0 (sv) |
IS (1) | IS7581A (sv) |
MX (1) | MXPA04011910A (sv) |
NO (1) | NO20044673L (sv) |
PL (1) | PL373409A1 (sv) |
RU (1) | RU2004131868A (sv) |
SE (1) | SE0201662D0 (sv) |
TW (1) | TW200307686A (sv) |
WO (1) | WO2003101956A1 (sv) |
ZA (1) | ZA200408787B (sv) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0401539D0 (sv) | 2004-06-15 | 2004-06-15 | Astrazeneca Ab | New compounds |
AR057064A1 (es) | 2005-06-13 | 2007-11-14 | Astrazeneca Ab | Compuestos para el tratamiento de arritmias cardiacas, formulacion farmaceutica y preparacion del compuesto |
AR053901A1 (es) * | 2005-06-20 | 2007-05-23 | Astrazeneca Ab | Formas fisicas de oxabispidinas n,n'- disustituidas |
JP5114880B2 (ja) | 2006-07-06 | 2013-01-09 | ダイキン工業株式会社 | 新規α−フルオロメトキシカルボン酸エステル、該α−フルオロメトキシカルボン酸エステルの製造方法及びセボフルランの製造方法 |
US9802954B2 (en) | 2011-08-24 | 2017-10-31 | Boehringer Ingelheim International Gmbh | Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma |
CN108314624B (zh) * | 2017-01-17 | 2022-09-27 | 东莞东阳光科研发有限公司 | 一种多氟苯胺的制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9903759D0 (sv) * | 1999-10-18 | 1999-10-18 | Astra Ab | Pharmaceutically active compounds |
AR035216A1 (es) * | 2000-12-01 | 2004-05-05 | Astrazeneca Ab | Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios |
-
2002
- 2002-05-31 SE SE0201662A patent/SE0201662D0/sv unknown
-
2003
- 2003-05-16 TW TW092113322A patent/TW200307686A/zh unknown
- 2003-05-27 BR BR0311138-5A patent/BR0311138A/pt not_active IP Right Cessation
- 2003-05-27 EP EP03756136A patent/EP1513807A1/en not_active Withdrawn
- 2003-05-27 WO PCT/SE2003/000854 patent/WO2003101956A1/en active Application Filing
- 2003-05-27 US US10/516,426 patent/US20060052314A1/en not_active Abandoned
- 2003-05-27 CN CNA038117347A patent/CN1656066A/zh active Pending
- 2003-05-27 RU RU2004131868/15A patent/RU2004131868A/ru not_active Application Discontinuation
- 2003-05-27 PL PL03373409A patent/PL373409A1/xx not_active Application Discontinuation
- 2003-05-27 CA CA002486110A patent/CA2486110A1/en not_active Abandoned
- 2003-05-27 JP JP2004509650A patent/JP2005532345A/ja active Pending
- 2003-05-27 MX MXPA04011910A patent/MXPA04011910A/es unknown
- 2003-05-27 AU AU2003232711A patent/AU2003232711A1/en not_active Abandoned
- 2003-05-28 AR ARP030101881A patent/AR040138A1/es not_active Application Discontinuation
-
2004
- 2004-10-28 NO NO20044673A patent/NO20044673L/no unknown
- 2004-10-29 ZA ZA200408787A patent/ZA200408787B/xx unknown
- 2004-11-11 IL IL16516904A patent/IL165169A0/xx unknown
- 2004-11-29 CO CO04120030A patent/CO5631429A2/es not_active Application Discontinuation
- 2004-12-03 IS IS7581A patent/IS7581A/is unknown
Also Published As
Publication number | Publication date |
---|---|
BR0311138A (pt) | 2005-03-01 |
PL373409A1 (en) | 2005-08-22 |
ZA200408787B (en) | 2005-10-20 |
IS7581A (is) | 2004-12-03 |
WO2003101956A1 (en) | 2003-12-11 |
EP1513807A1 (en) | 2005-03-16 |
IL165169A0 (en) | 2005-12-18 |
RU2004131868A (ru) | 2005-10-10 |
TW200307686A (en) | 2003-12-16 |
US20060052314A1 (en) | 2006-03-09 |
AU2003232711A1 (en) | 2003-12-19 |
JP2005532345A (ja) | 2005-10-27 |
AR040138A1 (es) | 2005-03-16 |
CO5631429A2 (es) | 2006-04-28 |
CA2486110A1 (en) | 2003-12-11 |
CN1656066A (zh) | 2005-08-17 |
NO20044673L (no) | 2004-12-07 |
MXPA04011910A (es) | 2005-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0215240A (pt) | Derivados de calcona e seu uso no tratamento de doenças | |
GB0005251D0 (en) | Therapeutic compounds | |
ATE346039T1 (de) | Sulfonamido-substituierte verbrückte bicycloalkylderivative | |
NO20060971L (no) | Pyridazinderivater og deres anvendelse som terapeutiske midler | |
ATE443043T1 (de) | Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer | |
DE50310516D1 (de) | Fredericamycin-derivate | |
EA200500853A1 (ru) | 2,4,6-тризамещённые пиримидины, являющиеся ингибиторами фосфотидилинозитол(pi)-3-киназы, и их применение при лечении рака | |
BG106825A (en) | Substituted oxazolidinones and their use in the field of blood coagulation | |
GB0225474D0 (en) | Therapeutic agents | |
BRPI0512253A (pt) | composto, formulação farmacêutica, uso de um composto, método de tratamento de uma doença, produto combinado, e, processo para a preparação de um composto | |
BRPI0512252A (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, formulação farmacêutica, uso de um composto, método de tratamento de uma doença, produto combinado, e, processo para a preparação de um composto | |
DK1288205T3 (da) | Nye phenylalanin-derivater | |
DE602004017194D1 (de) | Pyridylpyrrol-derivate als wirksame kinase-hemmer | |
ATE381537T1 (de) | Formanilid-derivative als beta2-adrenorezeptor- agonisten | |
ZA200508889B (en) | Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxomorpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor Xa in the treatment of thrombo-embolic diseases | |
DE502004005033D1 (de) | Substituierte 2-aminotetraline zur behandlung von depressionen | |
TR200200716T2 (tr) | Ketiyapin granülleri | |
CY1110130T1 (el) | Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α. | |
BR0316458A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto | |
ATE396986T1 (de) | Pyrimidylpyrrolderivate, die als kinaseinhibitoren wirken | |
BR0213037A (pt) | Derivados de pirimidina | |
SE0201662D0 (sv) | Pharmaceutical combination | |
AR021241A1 (es) | Inhibidores de proteasas | |
GEP20063754B (en) | Quinoline Derivatives and Use Thereof as Antitumor Agents | |
DK1174131T3 (da) | Anvendelse af et middel til forbedring af astrocytfunktion til behandling af Parkinsons sygdom |